After a decade of relying on blood transfusions for her congenital disorder, 11-year-old Dang Thanh Mai Thu is now recovering ...

Despite promising Phase 3 results, safety concerns, namely liver injury, have impacted Agios stock and could affect Pyrukund's approval and market adoption. Read the full report here.

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

The NTR Trust recently hosted a spectacular musical night, "Euphoria," in Vijayawada, Andhra Pradesh, to raise awareness and ...

DKMS Foundation India inaugurates new BMT unit in Ahmedabad, providing hope and treatment for thalassemia patients in Gujarat ...

Meerut: A 12-bed thalassemia ward at Saharanpur district hospital now provides free treatment to nearly 145 patients, thanks ...

A Thalassemia screening desk has been inaugurated at the NADRA centre in Sukkur on Saturday marking a significant step ...

In a heartwarming display of generosity, Andhra Pradesh Deputy Chief Minister Pawan Kalyan announced a substantial donation ...

Global Thalassemia Market Global Thalassemia Market Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Thalassemia Market by Treatment Type, by Type, by Distribution Channel, and by Region" report has ...

Filed for Regulatory Approval of Mitapivat (PYRUKYND®) for the Treatment of Adult Patients with Non-Transfusion-Dependent and ...